Intuitive Surgical (ISRG) Financial Analysis & Valuation | Quarter Chart
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both w... more
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $150.74B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | David J. Rosa |
| IPO Date | 2000-06-16 | CAGR | — |
| Employees | 17,021 | Website | www.intuitive.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 63.12% | Total Yield | 63.12% |
ISRG chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $140.61B | P/E | 44.36 | Forward P/E | 35.24 | PEG | 1.85 |
| P/S | 0.49 | P/B | 0.32 | P/CF | 1.62 | P/FCF | 1.94 |
| Sales | $11.03B | Sales 1Y | 20.66% | Sales 3Y | 65.57% | Sales 5Y | 113.72% |
| EPS | $9.62 | EPS 1Y | 22.59% | EPS 3Y | 120.3% | EPS 5Y | 96.64% |
| Sales QoQ | 4.39% | EPS QoQ | 3.07% | Sales QoQ Avg | 4.53% | EPS QoQ Avg | 6.83% |
| Gross Margin | 66.29% | Operating Margin | 30.45% | Profit Margin | 28.15% | ROCE | 17.71% |
| ROA | 15% | ROE | 17% | Altman Z Score | 36.87 | Piotroski Score | 8 |
| Current Ratio | 6.03 | Quick Ratio | 5.01 | Cash Ratio | 1.07 | Op. CF Ratio | 1.38 |
| Debt/Equity | — | Debt/Assets | — | Lt Debt/Equity | — | Lt Debt/Cap. | — |
| Intrst Cov. | — | Inventory Turnover | 1.83 | Asset Turnover | 0.53 | Receivables Turnover | 6.18 |
| Enterprise Value | $140.61B | P/E Ratio | 44.36 |
| Forward P/E | 35.24 | PEG Ratio | 1.85 |
| P/S Ratio | 0.49 | P/B Ratio | 0.32 |
| P/CF Ratio | 1.62 | P/FCF Ratio | 1.94 |
| EPS | $9.62 | EPS Growth 1Y | 22.59% |
| EPS Growth 3Y | 120.3% | EPS Growth 5Y | 96.64% |
| Revenue Growth 1Y | 20.66% | Gross Margin | 66.29% |
| Operating Margin | 30.45% | Profit Margin | 28.15% |
| ROE | 17% | ROA | 15% |
| ROCE | 17.71% | Current Ratio | 6.03 |
| Quick Ratio | 5.01 | Cash Ratio | 1.07 |
| Debt/Equity | — | Interest Coverage | — |
| Altman Z Score | 36.87 | Piotroski Score | 8 |
Intuitive Surgical (ISRG) valuation & financials
Intuitive Surgical (ISRG) has a market capitalization of $150.74B and trades at a price-to-earnings ratio of 44.4. It operates in the Healthcare sector (Medical - Devices).
Intuitive Surgical's revenue grew +20.7% over the last year.
Intuitive Surgical's next earnings report is scheduled for October 20, 2026 after market close (provider scheduled date); analysts estimate EPS of $2.64. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)